Core Viewpoint - Altria Group is gaining attention from institutional investors despite its association with tobacco products, as it offers stability and high dividend yields in a volatile market [2][3][15]. Group 1: Institutional Interest - A major institutional player acquired $1.3 billion worth of Altria Group shares, indicating significant interest from large investors [4]. - The stock is trading within 5% of a new 52-week high, suggesting bullish momentum and investor confidence [6]. Group 2: Financial Performance - Altria Group has a gross profit margin of 70.8%, showcasing its pricing power and market share [8][9]. - The company maintains a net income margin of 50.4%, allowing for efficient capital allocation [10]. - Altria generates an average return on invested capital (ROIC) of 40% annually, enabling reinvestment in growth and shareholder benefits [11]. Group 3: Dividend and Income Potential - The company offers a dividend yield of 6.9%, with an annual dividend payment of $4.08 per share, appealing to income-focused investors [13][14]. - Altria has a strong track record of dividend increases over 56 years, reinforcing its reliability as an income-generating asset [14][15].

Market Overview - U.S. stock markets are experiencing a positive trend after recent volatility, with the S&P 500 near its all-time high and both the Nasdaq Composite and Dow showing positive year-to-date performance [1][2] Economic Factors - Ongoing trade negotiations between the U.S. and China, stability in the U.S. labor market, and a declining inflation rate have improved market sentiment towards equities [2] Investment Opportunities - Non-tech stocks have shown significant appreciation year to date, alongside discussions of AI, quantum computing, and 5G/6G technologies [3] Recommended Stocks - Five corporate giants with market capitalizations over $50 billion have provided returns exceeding 40% year to date, all holding a Zacks Rank 1 (Strong Buy) [4][5] Howmet Aerospace Inc. (HWM) - Benefits from strong momentum in the commercial aerospace market and defense aerospace business, supported by rising U.S. and international defense budgets [8] - Expected revenue and earnings growth rates of 8.5% and 28.6% respectively for the current year, with a 4.2% improvement in earnings estimates over the last 30 days [9][10] Newmont Corp. (NEM) - Progressing with growth projects, including the Tanami expansion and the acquisition of Newcrest, which enhances operational synergies [11] - Expected revenue and earnings growth rates of 2% and 20.1% respectively for the current year, with a 9.7% improvement in earnings estimates over the last 30 days [12] Philip Morris International Inc. (PM) - Strong pricing power and an expanding smoke-free product portfolio, with products like IQOS and ZYN driving growth [13] - Expected revenue and earnings growth rates of 8.1% and 13.7% respectively for the current year, with a 4.6% improvement in earnings estimates over the last 60 days [15] NatWest Group plc (NWG) - Provides a range of banking and financial services, with expected revenue and earnings growth rates of 20.1% and 17.3% respectively for the current year, and a 6.8% improvement in earnings estimates over the last 30 days [16][17] Deutsche Bank Aktiengesellschaft (DB) - First-quarter 2025 results benefited from increased revenues and lower expenses, with a focus on stable, capital-light businesses driving revenue growth [18][19] - Expected revenue and earnings growth rates of 12% and over 100% respectively for the current year, with a 4.2% improvement in earnings estimates over the last 60 days [19]

Core Viewpoint - British American Tobacco (BTI) has been upgraded to a Zacks Rank 2 (Buy), indicating an upward trend in earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system emphasizes the importance of changing earnings estimates, which are strongly correlated with near-term stock price movements [4][6]. - Rising earnings estimates for British American Tobacco suggest an improvement in the company's underlying business, which could lead to higher stock prices [5][10]. Zacks Rating System - The Zacks Rank stock-rating system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have generated an average annual return of +25% since 1988 [7][9]. - The upgrade of British American Tobacco to a Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10]. Earnings Estimate Revisions - British American Tobacco is projected to earn $4.54 per share for the fiscal year ending December 2025, reflecting a year-over-year change of -1.9% [8]. - Over the past three months, the Zacks Consensus Estimate for British American Tobacco has increased by 1%, indicating a positive trend in earnings estimates [8].

Core Viewpoint - Altria Group, the largest cigarette maker in North America, is facing significant challenges due to declining cigarette volumes, despite rising earnings and dividends, raising concerns for investors [1][9]. Company Overview - Altria primarily focuses on cigarette production, with 14.2 billion cigarettes produced in Q1 2025, accounting for approximately 97% of its smokable products [3]. - Smokable products contribute around 88% to Altria's revenue, highlighting the importance of cigarettes to its business model [3]. Industry Trends - Cigarette volumes are declining, with a 13.7% decrease in production from nearly 16.5 billion in Q1 2024 to 14.2 billion in Q1 2025 [4]. - Historical data shows a significant drop from over 25 billion cigarettes produced in Q1 2020, indicating ongoing industry headwinds [4]. Company Strategies - Altria has attempted to mitigate the impact of declining cigarette demand through price increases, leveraging the addictive nature of nicotine to maintain some pricing power [5]. - However, recent trends suggest that price increases alone are insufficient to sustain revenue growth [6]. Financial Performance - Despite a year-over-year revenue decline of 5.7% in Q1 2025, generating approximately $5.3 billion compared to nearly $6.4 billion in 2020, Altria has managed to keep earnings and dividends rising [9]. - The company has reduced its share count from 1.758 billion in Q1 2024 to 1.69 billion in Q1 2025, primarily through stock buybacks, which has helped support earnings [7][10]. Future Outlook - While Altria currently offers a 6.7% dividend yield, the company must find alternatives to cigarettes to avoid a potential terminal decline [11].

Group 1 - The article discusses the significant opportunities in the green economy as the world seeks to reduce carbon emissions, highlighting a market-beating model portfolio and actionable research on undercovered stocks [1] - British American Tobacco (BAT) is mentioned, with previous valuations indicating approximately 12% price upside for 2025, suggesting potential for a larger increase amid current uncertainties [2] - The investing group Green Growth Giants, led by a macroeconomist with over 20 years of experience, focuses on generational opportunities in the green economy, providing deeper insights into this sector [2]

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Style Sc ...

Core Insights - Philip Morris International Inc. (PM) has seen a stock increase of 50.1% year to date, outperforming the Zacks Tobacco industry's 38.8% rise and the 7% growth of the Zacks Consumer Staples sector, while the S&P 500 has only increased by 0.9% [1][2][9] Performance Comparison - PM has outperformed competitors such as Altria Group, British American Tobacco, and Turning Point Brands, which have seen returns of 13.4%, 27.1%, and 24.7% respectively year to date [2] Factors Behind Growth - The surge in PM's stock is attributed to premium pricing in traditional tobacco, rapid expansion in smoke-free offerings, and tight cost controls [5] - As of June 4, 2025, PM's stock closed at $180.66, just 1.8% below its 52-week high, indicating potential for further growth [6] - PM's stock is trading above both its 50-day and 200-day moving averages, reflecting sustained upward momentum and investor confidence [7] Smoke-Free Business Expansion - Smoke-free net revenues increased by 20.4% in Q1 2025, driven by the expansion of IQOS, ZYN, and VEEV [9][10] - IQOS, PM's flagship product, saw a 9.4% growth in HTU-adjusted IMS, particularly in Japan and Europe, while ZYN shipments surged 53% to 202 million cans [11][12] - PM is now active in 95 markets with smoke-free offerings, confirming the effectiveness of its multi-category strategy [12] Traditional Tobacco Performance - PM's combustible tobacco business remains resilient, with flat reported net revenues but a 3.8% increase on an organic basis in Q1 2025 [13] - The company's global brand portfolio, led by Marlboro, gained market share, increasing PM's total cigarette category share by 0.4 percentage points to 24.8% [13] Financial Outlook - PM expects total volume growth of 2% in 2025, marking its fifth consecutive year of positive volume growth, with smoke-free products projected to grow by 12-14% [14] - Management forecasts net revenue growth of 6-8% on an organic basis, with adjusted EPS for 2025 expected to be between $7.36 and $7.49, indicating 12-14% growth from the previous year [15] Earnings Estimates - The Zacks Consensus Estimate for PM's 2025 earnings suggests a year-over-year growth of 13.7%, with the same for 2026 indicating an 11.7% increase [18] - For Q2 2025, adjusted EPS is projected to be between $1.80 and $1.85, reflecting year-over-year growth [17] Valuation Insights - PM is currently trading at a forward P/E ratio of 23.04, significantly above the tobacco industry average of 15.49, indicating strong investor confidence in its growth trajectory [20] - Compared to peers, PM commands a premium valuation, reflecting a market perception of it as a growth-oriented company within the tobacco industry [21][22] Conclusion - PM is positioned as a leader in the shift toward reduced-risk products, with strong pricing power, accelerating smoke-free growth, and consistent earnings momentum, making it an attractive long-term investment opportunity [24][25]

Core Insights - Altria Group, Inc. is progressing towards a smoke-free future, with its oral nicotine pouch brand on! being a significant growth driver as consumer preferences shift towards reduced-risk products [1][5] Group 1: Product Performance - In Q1 2025, on! shipment volume increased by 18% year over year, exceeding 39 million cans, and its retail market share in the oral tobacco category rose to 8.8%, a 1.8 share point increase [2][10] - Within the nicotine pouch segment, on! achieved a market share of 17.9%, gaining 0.5 points, indicating strong brand equity and consumer loyalty despite higher retail pricing [2][10] Group 2: Financial Performance - Altria's Oral Tobacco Products segment generated revenues of $654 million in Q1 2025, reflecting a 0.5% year-over-year increase, primarily driven by pricing strength [3][10] - The company's forward price-to-earnings ratio stands at 10.87X, which is below the industry average of 15.49X [12] Group 3: Strategic Initiatives - Altria has initiated the "Optimize & Accelerate" program, aiming for at least $600 million in cost savings over five years, focusing on enhancing efficiency and reinvesting in smoke-free innovations [4] - The company is positioning itself to lead in the smoke-free nicotine market, with on! becoming a cornerstone of its growth strategy [5] Group 4: Competitive Landscape - Key competitors in the smoke-free category include Philip Morris International and British American Tobacco, both of which are also shifting towards reduced-risk products [6][7][8] - Philip Morris reported that smoke-free products contributed 44% of its gross profit in Q1 2025, with significant growth in ZYN and VEEV shipments [7] - British American Tobacco aims to reach 50 million consumers by 2030, with its smokeless user base at 29.1 million in 2024 [8] Group 5: Earnings Estimates - The Zacks Consensus Estimate for Altria's 2025 earnings indicates a year-over-year growth of 4.5%, with 2026 estimates suggesting a 3.5% increase [13]

Core Viewpoint - Imperial Tobacco Group PLC (IMBBY) has received a Zacks Rank 2 (Buy) upgrade, indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][4]. Earnings Estimates and Revisions - The Zacks Consensus Estimate for Imperial Tobacco Group for the fiscal year ending September 2025 is projected at $4.17 per share, reflecting an 11.5% increase from the previous year's reported figure [9]. - Over the past three months, the Zacks Consensus Estimate for the company has risen by 2%, indicating a trend of increasing earnings estimates [9]. Zacks Rating System - The Zacks rating system is based on changes in a company's earnings picture, which is a critical determinant of stock price movements [2][3]. - The system classifies stocks into five groups, with Zacks Rank 1 (Strong Buy) to Zacks Rank 5 (Strong Sell), and has shown a strong track record, with Zacks Rank 1 stocks averaging a +25% annual return since 1988 [8]. Market Implications - The upgrade to Zacks Rank 2 places Imperial Tobacco Group in the top 20% of Zacks-covered stocks, suggesting a strong potential for market-beating returns in the near term due to favorable earnings estimate revisions [11]. - Rising earnings estimates and the corresponding rating upgrade indicate an improvement in the company's underlying business, which is expected to drive stock price appreciation [6].

Group 1 - The company is increasing its annual subscription price by 25% starting June 10th, encouraging current subscribers to lock in legacy pricing [1] - The focus of the investment group is on high return on equity and high free cash flow stocks that have a proven track record of compounding earnings at rates higher than the market [1] - The investment group provides in-depth research with 2-4 new high-quality investment ideas each month, which have historically earned returns well above benchmark levels [1] Group 2 - Thomas Lott leads the investment group Cash Flow Compounders, aiming to identify the best companies globally that are trading at attractive valuations [2] - The investment strategy is influenced by Graham and Dodd/Buffett style investing, focusing on high-quality equities at appealing valuations [2] - Thomas Lott has over 30 years of experience in the financial industry, starting as a portfolio manager at a hedge fund in 2003, and holds an MBA from Northwestern's Kellogg School of Management [2]